Total Payments
$775.69
2022 Payments
$12.98
Companies
16
Transactions
48
Medicare Patients
514
Medicare Billing
$40,394
Payment Breakdown by Category
Food & Beverage$775.69 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $775.69 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $139.35 | 11 | $0 (2019) |
| Novo Nordisk Inc | $131.54 | 7 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $95.57 | 6 | $0 (2021) |
| Allergan Inc. | $90.71 | 2 | $0 (2018) |
| Amgen Inc. | $62.92 | 4 | $0 (2021) |
| Abbott Laboratories | $42.14 | 3 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $34.50 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $31.46 | 2 | $0 (2018) |
| Lilly USA, LLC | $29.69 | 2 | $0 (2018) |
| PFIZER INC. | $27.66 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $12.98 | 1 | ABBVIE INC. ($12.98) |
| 2021 | $71.34 | 5 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($17.76) |
| 2020 | $43.72 | 3 | Novo Nordisk Inc ($29.26) |
| 2019 | $143.43 | 10 | Novo Nordisk Inc ($54.90) |
| 2018 | $304.32 | 17 | Allergan Inc. ($78.09) |
| 2017 | $199.90 | 12 | Novo Nordisk Inc ($47.38) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/02/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Neuromodulation | ||||||
| 04/22/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: PSYCHIATRY | ||||||
| 03/10/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Gastroenterology | ||||||
| 02/04/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Bone Health | ||||||
| 10/15/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Diabetes | ||||||
| 03/27/2020 | Abbott Laboratories | Axium INS DRG IPG (Device) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/06/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diabetes | ||||||
| 12/12/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 11/07/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Diabetes | ||||||
| 10/10/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: RESPIRATORY | ||||||
| 06/24/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Diabetes | ||||||
| 06/20/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: RESPIRATORY | ||||||
| 05/28/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/29/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Diabetes | ||||||
| 04/17/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/25/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: RESPIRATORY | ||||||
| 01/28/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: RESPIRATORY | ||||||
| 11/29/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/18/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/04/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Respiratory | ||||||
| 08/08/2018 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 07/30/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), BREO, INCRUSE | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 168 | 177 | $37,934 | $11,460 |
| 2020 | 4 | 346 | 474 | $89,493 | $28,934 |
Total Patients
514
Total Services
651
Medicare Billing
$40,394
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 47 | 47 | $8,731 | $6,048 | 69.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 121 | 130 | $29,203 | $5,412 | 18.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 132 | 132 | $16,500 | $14,752 | 89.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 156 | 283 | $63,573 | $11,879 | 18.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 30 | 30 | $4,973 | $1,582 | 31.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 28 | 29 | $4,447 | $720.97 | 16.2% |
About Dr. Michael Pass, MD
Dr. Michael Pass, MD is a Family Medicine healthcare provider based in Waynesville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497843486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Pass, MD has received a total of $775.69 in payments from pharmaceutical and medical device companies, with $12.98 received in 2022. These payments were reported across 48 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($775.69).
As a Medicare-enrolled provider, Pass has provided services to 514 Medicare beneficiaries, totaling 651 services with total Medicare billing of $40,394. Data is available for 2 years (2020–2021), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Waynesville, NC
- Active Since 10/11/2006
- Last Updated 09/04/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1497843486
Products in Payments
- XIFAXAN (Drug) $110.72
- TRELEGY ELLIPTA (Drug) $100.00
- VRAYLAR (Drug) $90.71
- Ozempic (Drug) $70.44
- Prolia (Biological) $49.45
- Victoza (Drug) $47.38
- ANORO (Drug) $27.86
- CHANTIX (Drug) $27.66
- UBRELVY (Drug) $24.05
- SYMBICORT (Drug) $20.54
- FORTEO (Drug) $18.77
- CAPLYTA (Drug) $14.58
- Axium INS DRG IPG (Device) $14.46
- Proclaim IPG (Device) $14.46
- Tresiba (Drug) $13.72
- EVENITY (Biological) $13.47
- Proclaim Family of SCS IPGs (Device) $13.22
- TOUJEO (Drug) $12.82
- INVOKANA (Drug) $12.49
- SHINGRIX (Biological) $11.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Waynesville
Dr. Paul Opsahl, Md, MD
Family Medicine — Payments: $27,966
Family Medicine $27,966
Mr. Michael Brown, Md, MD
Family Medicine — Payments: $14,870
Family Medicine $14,870
Benjamin Mayer, Do, DO
Family Medicine — Payments: $4,797
Family Medicine $4,797
Claudia Peters, M.d, M.D
Family Medicine — Payments: $4,403
Family Medicine $4,403
Ameer Shams, Md, MD
Family Medicine — Payments: $3,233
Family Medicine $3,233
David Wangerin Lile, Pa-C, PA-C
Family Medicine — Payments: $2,411
Family Medicine $2,411